Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 150-158

  Walker, Ellen A ^a,b   Picker, Mitchell J ^a   Granger, Arthur ^a   Dykstra, Linda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; BUPRENORPHINE; BUTORPHANOL; DEXAMPHETAMINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DEZOCINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; FENTANYL; FEPRADINOL; KAPPA OPIATE RECEPTOR AGONIST; LEVALLORPHAN; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALBUPHINE; NALORPHINE; NALTREXONE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; SPIRADOLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG EFFICACY; NONHUMAN; OPIATE ADDICTION; PIGEON; PRIORITY JOURNAL; TRAINING;

ANIMALS; COLUMBIDAE; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; MORPHINE; MORPHINE DEPENDENCE; NALBUPHINE; NARCOTICS; SODIUM CHLORIDE;

EID: 3042554964     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.058503     Document Type: Article

References (39)

1. Alt A, McFadyen IJ, Fan CD, Woods JH, and Traynor JR (2001) Stimulation of guanosine-5′-O-(3-[35S)thio)triphosphate binding digitonin- permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. J Pharmacol Exp Ther 298:116-121.
2. Colpaert FC, Niemegeers CJE, and Janssen PAJ (1980) Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination. Neuropharmacology 19:705-713.
3. Easterling KW and Holtzman SG (1999) Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat. J Pharmacol Exp Ther 288:1269-1277.
4. Emmerson PJ, Clark MJ, Mansour A, Akil H, and Woods JH (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther 278:1121-1127.
5. France CP, Adams JU, and Woods JH (1985) Intracerebroventricular drug administration in pigeons. Pharmacol Biochem Behav 23:731-736.
6. France CP, DeCosta BR, Jacobson AE, Rice KC, and Woods JH (1990) Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. J Pharmacol Exp Ther 252:600-604.
7. France CP and Woods JH (1987) Morphine, saline and naltrexone discrimination in morphine-treated pigeons. J Pharmacol Exp Ther 242:195-202.
8. France CP and Woods JH (1989) Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 250:937-943.
9. France CP and Woods JH (1990) Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J Pharmacol Exp Ther 254:626-632.
10. France CP and Woods JH (1993) U-50,488, saline and naltrexone discrimination in U-50,488-treated pigeons. Behav Pharmacol 4:509-516.
11. Gellert VF and Holtzman SG (1979) Discriminative stimulus effects of naltrexone in the morphine-dependent rat. J Pharmacol Exp Ther 211:596-605.
12. Gerak LR and France CP (1996) Discriminative stimulus effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 276:523-531.
13. Holtzman SG (1985) Drug discrimination studies. Drug Alcohol Depend 14:263-282.
14. Holtzman SG (2003) Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence. J Pharmacol Exp Ther 304:1033-1041.
15. Jewett DC, Mosberg HI, and Woods JH (1996) Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5- enkephalin) in pigeons. Psychopharmacology 127:225-230.
16. Karten HJ and Hodos W (1967) A Stereotaxic Atlas of the Brain of the Pigeon (Columba livia). John Hopkins Press, Baltimore, MD.
17. Koek W, Kleer E, Mudar PJ, and Woods JH (1986) Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5- phosphonovalerate. Behav Brain Res 19:257-259.
18. Morgan D and Picker MJ (1998) The μ opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the μ opioid receptor. Psychopharmacology 140:20-28.
19. Picker MJ (1994) Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure. J Pharmacol Exp Ther 268:1190-1198.
20. Picker MJ (1997) Discriminative stimulus effects of the mixed-opioid agonist/ antagonist dezocine: cross-substitution by Mu and Delta opioid agonists. J Pharmacol Exp Ther 283:1009-1017.
21. Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, and Smith MA (1996) Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists. J Pharmacol Exp Ther 279:1130-1141.
22. Picker MJ and Cook CD (1997) Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity. Behav Pharmacol 8:160-173.
23. Picker MJ and Cook CD (1998) Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline. Behav Pharmacol 9:319-328.
24. Preston KL, Bigelow GE, and Liebson IA (1989) Antagonist effects of nalbuphine in opioid-dependent human volunteers. J Pharmacol Exp Ther 248:929-937.
25. Preston KL, Bigelow GE, and Liebson IA (1990) Discrimination of butorphanol and nalbuphine in opioid-dependent humans. Pharmacol Biochem Behav 37:511-522.
26. Selley DE, Liu QX, and Childers SR (1998) Signal transduction correlates of μ opioid agonist intrinsic efficacy: receptor stimulative [35S]GTPγS binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285:496-505.
27. Shannon HE and Holtzman SG (1977) Further evaluation of the discriminative effects of morphine in the rat. J Pharmacol Exp Ther 201:55-66.
28. Shannon HE and Holtzman SG (1979) Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology 61:239-244.
29. Traynor JR and Nahorski SR (1995) Modulation by mu-opioid agonists of guanosine-5′-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
30. Vanecek SA and Young AM (1995) Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behav Pharmacol 6:669-681.
31. Villarreal JE and Karbowski MG (1974) The actions of narcotic antagonists in morphine-dependent rhesus monkeys, in Narcotic Antagonists (Braude MC, Harris LS, May EL, Smith JP, Villarreal JE eds), vol 8, pp 273-289, Advances in Biochemical Psychopharmacology, Raven Press, New York.
32. Walker EA, Picker MJ, and Dykstra LA (2001) Three-choice discrimination in pigeons is based on relative efficacy differences among opioids. Psychopharmacology 155:389-396.
33. Walker EA, Richardson TM, and Young AM (1996) In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine. Psychopharmacology 125:113-119.
34. Walker EA and Young AM (1993) Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J Pharmacol Exp Ther 267:322-330.
35. Walker EA, Zernig G, and Young AM (1998) In vivo apparent affinity and efficacy estimates for μ opiates in a rat tail-withdrawal assay. Psychopharmacology 136: 15-23.
36. White DA and Holtzman SG (2003) Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey. Psychopharmacology 167: 203-210.
37. Young AM, Kapitsopoulos G, and Makhay MM (1991) Tolerance to morphine-like stimulus effects of mu opioid agonists. J Pharmacol Exp Ther 257:795-805.
38. Young AM, Masaki MA, and Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246-257.
39. Zhang L, Walker EA, Sutherland J, and Young AM (2000) Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology 148:136-145.